Kynexis Raises $40.

Zenalyst.AI

Zenalyst.AI builds an autonomous AI workforce that unifies ERP, CRM, banking, content and spreadsheets into a single intelligence layer, enabling real‑time analysis, scenario planning and decision automation to transform fragmented data into faster, smarter business decisions.

Ours Privacy

We believe that you shouldn’t have to choose between growth and patient privacy. Our HIPAA-compliant customer data platform enables marketers to use best in class tools - GTM, GA4, Google Ads, Meta, and more - without sacrificing patient privacy. Our CDP removes PHI so you can optimize every step of your funnel with confidence. Ours Privacy is built by experts in healthcare, martech, and security, helping you scale responsibly, with confidence. We're lucky to be backed by an experienced group of investors, including Serena Ventures, Adam Grant, Lakehouse, Andy Dunn, TMV, Bullish, Collab Fund, GreyMatter, Switch Ventures and more.

Renata Medical

At Renata Medical, we are redefining how congenital heart disease is treated—starting with the smallest patients and the biggest challenges. Built in close partnership with physicians, families, and hospitals, our innovations are grounded in real clinical needs and long-term outcomes. We exist to push the field forward—and to help more children live longer, healthier lives. In August, 2024, the Minima Stent System became the first and only FDA-approved stent designed for neonates, infants, and young children. Not only can it be implanted in small vessels, but can also be expanded over the course of their adolescence up to adult sizes. The Minima Stent System is currently available in the U.S., with plans to expand access to Europe and Asia in the near future.